|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/426 | (2006.01) |
| A61P 37/06 | (2006.01) | ||
| A61P 17/06 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 11/06 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 11/02 | (2006.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61P 1/04 | (2006.01) |
| (11) | Number of the document | 3256125 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15807916.0 |
| Date of filing the European patent application | 2015-12-10 | |
| (97) | Date of publication of the European application | 2017-12-20 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-26 |
| (46) | Date of publication of the claims translation | 2022-04-11 |
| (86) | Number | PCT/EP2015/079208 |
| Date | 2015-12-10 |
| (87) | Number | WO 2016/091996 |
| Date | 2016-06-16 |
| (30) | Number | Date | Country code |
| PCT/EP2014/077469 | 2014-12-11 | WO | |
| PCT/EP2015/058202 | 2015-04-15 | WO |
| (72) |
DINGEMANSE, Jasper , CH
HOCH, Matthias , GB
KRAUSE, Andreas , CH
|
| (73) |
Laboratoires Juvise Pharmaceuticals ,
149 boulevard Bataille de Stalingrad, 69100 Villeurbanne,
FR
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Ponezimodo, selektyviojo S1P1 receptorių agonisto, dozavimo režimas |
| DOSING REGIMEN FOR PONESIMOD, A SELECTIVE S1P1 RECEPTOR AGONIST |
| Payment date | Validity (years) | Amount | |
| 2025-11-24 | 11 | 289.00 EUR |
| 2026-12-10 |